IL-1 beta anticorps (AA 249-269) (Magnetic Particles)
Aperçu rapide pour IL-1 beta anticorps (AA 249-269) (Magnetic Particles) (ABIN1493417)
Antigène
Voir toutes IL-1 beta (IL1B) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 249-269
-
Specificité
- Human No cross reactivity with other proteins.
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Synthetic peptide corresponding to a sequence at the C-terminal of human IL1B (249-269 aa), identical to the related mouse and rat sequence.
Type of Immunogen: Synthetic peptide
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 1 mg/mL magnetic beads in PBS, pH 7.2, 0.05 mg sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 4°C.
-
-
- IL-1 beta (IL1B) (Interleukin 1, beta (IL1B))
-
Autre désignation
- IL1B
-
Sujet
-
Name/Gene ID: IL1B
Family: IL-1
Synonyms: IL1B, IL-1B, IL-1 beta, IL1-BETA, Preinterleukin 1 beta, Pro-interleukin-1-beta, Catabolin, IL-1, IL1F2, Interleukin 1, beta, Interleukin-1 beta -
ID gène
- 3553
-
UniProt
- P01584
-
Pathways
- Signalisation NF-kappaB, Interferon-gamma Pathway, Signalisation TLR, Negative Regulation of Hormone Secretion, Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Glycosaminoglycan Metabolic Process, Myometrial Relaxation and Contraction, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Autophagy, Cancer Immune Checkpoints, Inflammasome
Antigène
-